Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.67B |
| 2 |
Apple
AAPL
|
+$1.5B |
| 3 |
Tesla
TSLA
|
+$1.38B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.27B |
| 5 |
Mastercard
MA
|
+$1.1B |
Top Sells
| 1 |
Honeywell
HON
|
+$1.28B |
| 2 |
Phillips 66
PSX
|
+$651M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$503M |
| 4 |
Materials Select Sector SPDR Fund
XLB
|
+$425M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$377M |
Sector Composition
| 1 | Technology | 28.23% |
| 2 | Financials | 14.76% |
| 3 | Consumer Discretionary | 11.75% |
| 4 | Healthcare | 8.95% |
| 5 | Communication Services | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Geospace Technologies
GEOS
$212M
| $89K | ﹤0.01% |
12,280
-6,038
| -33% | -$43.8K |
|
3602
Lineage Cell Therapeutics
LCTX
$295M
| $89K | ﹤0.01% |
195,045
-39,024
| -17% | -$17.8K |
|
|
NYAX
3603
Nayax
NYAX
$1.87B
| $89K | ﹤0.01% |
2,641
+360
| +16% | +$12.1K |
|
3604
SPDR Portfolio S&P 500 ETF
SPLG
$85.8B
| $89K | ﹤0.01% |
1,350
| – | – |
|
3605
Vanguard Real Estate ETF
VNQ
$35B
| $89K | ﹤0.01% |
975
+19
| +2% | +$1.73K |
|
3606
Paysign
PAYS
$290M
| $88K | ﹤0.01% |
41,104
-11,074
| -21% | -$23.7K |
|
|
MBX
3607
MBX Biosciences, Inc. Common Stock
MBX
$334M
| $88K | ﹤0.01% |
11,818
-5,615
| -32% | -$41.8K |
|
3608
Atossa Therapeutics
ATOS
$106M
| $87K | ﹤0.01% |
128,578
-63,376
| -33% | -$42.9K |
|
3609
Nautilus Biotechnolgy
NAUT
$89.2M
| $87K | ﹤0.01% |
100,967
-24,237
| -19% | -$20.9K |
|
3610
ReNew
RNW
$2.76B
| $87K | ﹤0.01% |
14,773
-17,350
| -54% | -$102K |
|
3611
Atomera
ATOM
$103M
| $86K | ﹤0.01% |
21,436
+11,436
| +114% | +$45.9K |
|
3612
B. Riley Financial
RILY
$190M
| $86K | ﹤0.01% |
22,364
-33,283
| -60% | -$128K |
|
3613
TScan Therapeutics
TCRX
$105M
| $86K | ﹤0.01% |
61,850
-5,658
| -8% | -$7.87K |
|
3614
Tango Therapeutics
TNGX
$761M
| $86K | ﹤0.01% |
63,032
-36,742
| -37% | -$50.1K |
|
3615
Twin Disc
TWIN
$187M
| $86K | ﹤0.01% |
11,301
-5,491
| -33% | -$41.8K |
|
|
IMA
3616
ImageneBio, Inc. Common Stock
IMA
$103M
| $85K | ﹤0.01% |
5,515
-10,761
| -66% | -$166K |
|
3617
Riskified
RSKD
$732M
| $85K | ﹤0.01% |
18,433
-1,486
| -7% | -$6.85K |
|
3618
Veru
VERU
$52.2M
| $85K | ﹤0.01% |
17,225
-3,427
| -17% | -$16.9K |
|
3619
Vanguard Growth ETF
VUG
$189B
| $84K | ﹤0.01% |
227
-9,395
| -98% | -$3.48M |
|
3620
inTEST
INTT
$89.3M
| $83K | ﹤0.01% |
11,846
-1,627
| -12% | -$11.4K |
|
3621
Perion Network
PERI
$422M
| $83K | ﹤0.01% |
10,232
| – | – |
|
3622
SES AI
SES
$424M
| $83K | ﹤0.01% |
160,388
-36,331
| -18% | -$18.8K |
|
3623
Trinseo
TSE
$87.4M
| $83K | ﹤0.01% |
22,537
-25,815
| -53% | -$95.1K |
|
3624
Lakeland Industries
LAKE
$135M
| $82K | ﹤0.01% |
3,991
-6,736
| -63% | -$138K |
|
3625
Acumen Pharmaceuticals
ABOS
$84.2M
| $80K | ﹤0.01% |
72,265
-20,817
| -22% | -$23K |
|